This suggests that the role of TGF-β in OSCC on tumor cells and on immune cells and their bidirectional connection may be relatively complicated and needs further research, especially in the context of potential dual PD-1 and TGF-β inhibition in the future. The gene discussed is TGFB1; the disease is neoplasm.